REQUEST A DEMO
Total
USD $0.00
Search more companies

Austromedex CIA Ltda (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Austromedex CIA Ltda Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Austromedex CIA Ltda is a company in Ecuador, with a head office in Cuenca. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Austromedex CIA Ltda was incorporated on April 12, 2013. Austromedex CIA Ltda currently employs 2 (2023) people. The latest financial highlights indicate a net sales revenue increase of 1.05% in 2023. There was a total growth of 2.28% in Austromedex CIA Ltda’s total assets over the same period. The enterprise’s net profit margin increased by 23.76% in 2023.

Headquarters
Aurelio Aguilar , Floor 1
Cuenca; Azuay;

Contact Details: Purchase the Austromedex CIA Ltda report to view the information.

Basic Information
Total Employees:
Purchase the Austromedex CIA Ltda report to view the information.
Outstanding Shares:
Purchase the Austromedex CIA Ltda report to view the information.
Registered Capital:
Purchase the Austromedex CIA Ltda report to view the information.
Incorporation Date:
April 12, 2013
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
99%
Purchase this report to view the information.
1%
Company Performance
Financial values in the chart are available after Austromedex CIA Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
1.05%
Total operating revenue
1.05%
Operating profit (EBIT)
1590.42%
EBITDA
146.78%
Net Profit (Loss) for the Period
1920.56%
Total assets
2.28%
Total equity
22.09%
Operating Profit Margin (ROS)
23.53%
Net Profit Margin
23.76%
Return on Equity (ROE)
17.12%
Debt to Equity Ratio
18%
Quick Ratio
3.18%
Cash Ratio
1.42%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?